Skip to content

CVS HEALTH CORPORATION (CVS) — DCF Valuation Summary

Based on a DCF model, CVS HEALTH CORPORATION (CVS) has an estimated fair value of $138.77, compared to a current price of $93.02.

Model Assumptions & Verdict

Using a WACC of 6.3%, a terminal growth rate of 2.0%, and projected FCF growth of -1.2%, the model suggests CVS is currently undervalued with upside/downside of +49.2% versus the current price.

Verdict: UndervaluedUpside / Downside: +49.2%

DeepViews
VALUATION

DCF Valuation Calculator

[01]
Enter Company Ticker
Quick search:
Model Inputs & Results
[02]DCF Assumptions

Growth Stage

Rate declines linearly to terminal rate over projection period

$0

Negative or zero FCF — DCF model is not applicable. Enter a positive value or use alternative valuation methods.

10.0%
-10%40%

Terminal Stage

Perpetuity growth after projection period

2.5%
0%5%
10.0%
4%20%
$0
0.00B

Search for a company to start DCF analysis

Enter a ticker symbol and data will auto-populate into the model

Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.

CVS HEALTH CORPORATION (CVS) DCF Valuation — Discounted Cash Flow Calculator | $119.0B Market Cap | DeepViews